Introduction
It has been shown that stress can either increase or decrease immune function depending on a variety of factors including duration of stressful situation (Dhabhar, 2014; Hu et al., 2014; Li et al., 2014a,b,c) . Acute stress enhances immune response, however, chronic stress induces a suppressive effect on the bodily defense system (Dhabhar, 2014; Hu et al., 2014) . Our previous studies have shown that reduction of immune responses occurs in chronic restraint stress (Hu et al., 2014; Li et al., 2011) . Chronic stress conditions can disrupt immune cell responses particularly by altering patterns of cytokine secretion (Hu et al., 2013 (Hu et al., , 2014 Li et al., 2011) . This process results in the suppression of Type 1 helper T cells (Th1) with a subsequent increase in Th2 response, also increases the apoptosis of T cell and dendritic cell (Li et al., 2011; Li et al., 2014a,b,c) . And it also enhances the differentiation of suppressor cells, such as T regulatory (Treg) cells, rendering the defense system vulnerable to pathogenic infections and autoimmune diseases (Hou et al., 2016; Jin et al., 2013) . Elucidation of the cell signal regulatory mechanism is fundamental to understand how the immune suppression has been triggered in chronic stress.
Toll-like receptors (TLRs) are an ancient and evolutionarily conserved receptor family that plays a critical role in the innate immune and inflammatory responses (Babdor et al., 2017; Li et al., 2014a,b,c) . Engagement of ligands to respective TLRs initiates series of intracellular signaling events, and then activates multiple downstream pathways to regulate the apoptosis of lymphocytes or the secretion of pro-inflammatory and anti-inflammatory factors subsequently (Hu et al., 2014; Takeuchi and Akira, 2010) . TLR9 is subcellular localized in endosomal, and can be activated by circulation mtDNA (Medzhitov, 2001) . After recognition of their ligands, TLR9 activates intracellular signaling pathways such as MAPKs (p38, ERK, and JNK) resulting in the transcription of inflammatory and immunomodulatory genes including chemokines, cytokines and co-stimulatory molecules (Gu et al., 2015) . Previous reports demonstrated that the activation TLR9 could induce production of TGF-β1 and was related to autoimmunity and fibrosis (Fang et al., 2016; Li et al., 2014a,b,c) . The activation of p38 MAPK (Kamaraju and Roberts, 2005) and ERK MAPK (Hayashida et al., 2003) may augment Smad signaling, and activation of p38 MAPK may act downstream of TGF-β1, mediating TGF-β1-dependent apoptosis. Confirmation of these phenotypes of TLR9 and TGF-β1 signal led us to our hypothesis that TLR9/MAPK pathway activated TGF-β1/Smad2/3 signal to mediate immune responses during chronic stress.
